Alternatives to Cognito Therapeutics

Developing non-invasive ultrasound technology to treat age-related brain diseases like Alzheimer's.

Global network of clinics using AI and data science to treat age-related cognitive and functional decline.

FIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.

AI-powered platform for early Alzheimer's detection and personalized care.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing.

Developing ultrasound-mediated nonviral genetic medicines.

DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing lightweight bionic technology.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.